Tigran Torosian

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.

Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.

Journal: Bone marrow transplantation

Published: November 13, 2021

Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.

Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.

Journal: Bone marrow transplantation

Published: February 07, 2020

Immunogenetics in stem cell donor registry work: The DKMS example (Part 2).

Immunogenetics in stem cell donor registry work: The DKMS example (Part 2).

Journal: International journal of immunogenetics

Published: December 02, 2019

Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).

Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).

Journal: International journal of immunogenetics

Published: November 18, 2019

Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0.

Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0.

Journal: HLA

Published: August 23, 2019

Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation.

Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation.

Journal: Diabetes research and clinical practice

Published: January 09, 2018

Audits of collection and apheresis centers: guidelines by the World Marrow Donor Association Working Group Quality and Regulation.

Audits of collection and apheresis centers: guidelines by the World Marrow Donor Association Working Group Quality and Regulation.

Journal: Bone marrow transplantation

Published: December 04, 2017

Bone marrow harvest from unrelated donors-up-to-date methodology.

Bone marrow harvest from unrelated donors-up-to-date methodology.

Journal: European journal of haematology

Published: July 12, 2017

Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.

Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.

Journal: Annals of hematology

Published: June 02, 2016

Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.

Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: July 12, 2015

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group.

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group.

Journal: Leukemia research

Published: June 28, 2015

Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.

Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.

Journal: Bone marrow transplantation

Published: May 19, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026